Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingvild Odsbu

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Plos One|August 11, 2022
Association between folic acid use during pregnancy and gestational diabetes mellitus: Two population-based Nordic cohort studiesLaura Pazzagli, Silvia Segovia Chacón, Christos Karampelias, et al.
Pharmacoepidemiology and Drug Safety|August 9, 2020
In utero opioid exposure and risk of infections in childhood: A multinational Nordic cohort studyMilada Mahic, Sonia Hernandez-Diaz, Mollie Wood, et al.
European Addiction Research|June 29, 2023
Cause-Specific Mortality among Patients in Treatment for Opioid Use Disorder in Multiple Settings: A Prospective Comparative Cohort StudyDesiree Eide, Svetlana Skurtveit, Thomas Clausen, et al.
BMJ Open|August 28, 2020
On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017Christer Frode Aas, Jørn Henrik Vold, Svetlana Skurtveit, et al.
Acta Psychiatrica Scandinavica|May 26, 2026
Socioeconomic Position and Somatic Comorbidity in Mental DisordersMartin Tesli, Vidar Hjellvik, Simon Lergenmuller, et al.
Drug Safety|April 26, 2023
Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countriesElena Dudukina, Szimonetta Komjáthiné Szépligeti, Pär Karlsson, et al.
Current Medical Research and Opinion|February 16, 2021
A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladderKelesitse Phiri, Jesper Hallas, Marie Linder, et al.
Pharmacoepidemiology and Drug Safety|April 29, 2024
Lessons learned from a multi-data source research collaboration: The mirabegron post-authorization safety study programStefan de Vogel, John D Seeger, Alejandro Arana, et al.
Drug Safety|May 29, 2019
Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort StudyAlicia Gilsenan, Joan Fortuny, Miguel Cainzos-Achirica, et al.
Drug Safety|July 8, 2021
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort StudyVeena Hoffman, Jesper Hallas, Marie Linder, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Plos One|August 11, 2022
Association between folic acid use during pregnancy and gestational diabetes mellitus: Two population-based Nordic cohort studiesLaura Pazzagli, Silvia Segovia Chacón, Christos Karampelias, et al.
Pharmacoepidemiology and Drug Safety|August 9, 2020
In utero opioid exposure and risk of infections in childhood: A multinational Nordic cohort studyMilada Mahic, Sonia Hernandez-Diaz, Mollie Wood, et al.
European Addiction Research|June 29, 2023
Cause-Specific Mortality among Patients in Treatment for Opioid Use Disorder in Multiple Settings: A Prospective Comparative Cohort StudyDesiree Eide, Svetlana Skurtveit, Thomas Clausen, et al.
BMJ Open|August 28, 2020
On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017Christer Frode Aas, Jørn Henrik Vold, Svetlana Skurtveit, et al.
Acta Psychiatrica Scandinavica|May 26, 2026
Socioeconomic Position and Somatic Comorbidity in Mental DisordersMartin Tesli, Vidar Hjellvik, Simon Lergenmuller, et al.
Drug Safety|April 26, 2023
Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countriesElena Dudukina, Szimonetta Komjáthiné Szépligeti, Pär Karlsson, et al.
Current Medical Research and Opinion|February 16, 2021
A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladderKelesitse Phiri, Jesper Hallas, Marie Linder, et al.
Pharmacoepidemiology and Drug Safety|April 29, 2024
Lessons learned from a multi-data source research collaboration: The mirabegron post-authorization safety study programStefan de Vogel, John D Seeger, Alejandro Arana, et al.
Drug Safety|May 29, 2019
Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort StudyAlicia Gilsenan, Joan Fortuny, Miguel Cainzos-Achirica, et al.
Drug Safety|July 8, 2021
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort StudyVeena Hoffman, Jesper Hallas, Marie Linder, et al.
Pageof 7